Reach out and get your patients to read

Article

Intervention to prevent reading problems needs to occur long before first grade. Incorporating a reading promotion program into your practice can improve the reading ability of children and bestow lifelong benefits.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Related Content
LLS

Olivia is helping patients and families understand the experience of blood cancer

The Leukemia & Lymphoma Society
June 18th 2025
Article
Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
AAP issues updated guidance on contraception for adolescents | Image Credit: © New Africa - stock.adobe.com.

AAP updates guidance on contraception for adolescents

Morgan Ebert, Managing Editor
June 18th 2025
Article

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA approves garadacimab-gxii to prevent HAE attacks in patients aged 12 years, older | Image credit: Contemporary Pediatrics

FDA approves garadacimab-gxii to prevent HAE attacks in patients aged 12 years, older

Joshua Fitch, Senior Editor
June 17th 2025
Article

Garadacimab-gxii is the only treatment to target factor Xlla for prophylactic use to prevent attacks of HAE in patients aged 12 years and older.

FDA will not meet original PDUFA data for sebetralstat to treat HAE | Image Credit: Contemporary Pediatrics

FDA will not meet original PDUFA date for sebetralstat to treat HAE

Joshua Fitch, Senior Editor
June 16th 2025
Article

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks.

© 2025 MJH Life Sciences

All rights reserved.